Annual Total Liabilities
$149.46 M
-$37.53 M-20.07%
December 31, 2023
Summary
- As of February 7, 2025, TNGX annual total liabilities is $149.46 million, with the most recent change of -$37.53 million (-20.07%) on December 31, 2023.
- During the last 3 years, TNGX annual total liabilities has fallen by -$19.19 million (-11.38%).
- TNGX annual total liabilities is now -20.07% below its all-time high of $186.99 million, reached on December 31, 2022.
Performance
TNGX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$123.25 M
-$10.54 M-7.87%
September 30, 2024
Summary
- As of February 7, 2025, TNGX quarterly total liabilities is $123.25 million, with the most recent change of -$10.54 million (-7.87%) on September 30, 2024.
- Over the past year, TNGX quarterly total liabilities has dropped by -$26.21 million (-17.54%).
- TNGX quarterly total liabilities is now -35.50% below its all-time high of $191.08 million, reached on September 30, 2022.
Performance
TNGX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TNGX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.1% | -17.5% |
| 3 y3 years | -11.4% | -30.2% |
| 5 y5 years | -11.4% | -30.2% |
TNGX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.1% | at low | -35.5% | at low |
| 5 y | 5-year | -20.1% | at low | -35.5% | at low |
| alltime | all time | -20.1% | at low | -35.5% | at low |
Tango Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $123.25 M(-7.9%) |
| Jun 2024 | - | $133.78 M(-5.6%) |
| Mar 2024 | - | $141.77 M(-5.1%) |
| Dec 2023 | $149.46 M(-20.1%) | $149.46 M(-1.4%) |
| Sep 2023 | - | $151.59 M(-8.9%) |
| Jun 2023 | - | $166.38 M(-5.7%) |
| Mar 2023 | - | $176.51 M(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $186.99 M(+20.3%) | $186.99 M(-2.1%) |
| Sep 2022 | - | $191.08 M(+27.6%) |
| Jun 2022 | - | $149.69 M(-1.0%) |
| Mar 2022 | - | $151.17 M(-2.7%) |
| Dec 2021 | $155.41 M(-7.9%) | $155.41 M(-5.7%) |
| Sep 2021 | - | $164.72 M(-2.3%) |
| Dec 2020 | $168.65 M | $168.65 M |
FAQ
- What is Tango Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Tango Therapeutics?
- What is Tango Therapeutics annual total liabilities year-on-year change?
- What is Tango Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Tango Therapeutics?
- What is Tango Therapeutics quarterly total liabilities year-on-year change?
What is Tango Therapeutics annual total liabilities?
The current annual total liabilities of TNGX is $149.46 M
What is the all time high annual total liabilities for Tango Therapeutics?
Tango Therapeutics all-time high annual total liabilities is $186.99 M
What is Tango Therapeutics annual total liabilities year-on-year change?
Over the past year, TNGX annual total liabilities has changed by -$37.53 M (-20.07%)
What is Tango Therapeutics quarterly total liabilities?
The current quarterly total liabilities of TNGX is $123.25 M
What is the all time high quarterly total liabilities for Tango Therapeutics?
Tango Therapeutics all-time high quarterly total liabilities is $191.08 M
What is Tango Therapeutics quarterly total liabilities year-on-year change?
Over the past year, TNGX quarterly total liabilities has changed by -$26.21 M (-17.54%)